Skip to main content

Clinical Implications of Combination Therapy on the Future of Asthma Management

Buy Article:

$31.50 plus tax (Refund Policy)

Current guidelines for the treatment of moderate persistent asthma list the combination of long-acting -agonists and inhaled corticosteroids (ICSs) as the treatment of choice. This decision is based on their efficacy compared with other dual controller combinations such as increased doses of ICSs or adding leukotriene modifiers, especially when the forced expiratory volume in 1 second value is used as the primary comparator. The main purpose of this study is to examine this form of dual controller therapy in terms of anti-inflammatory effects. One of the concerns with the combination of long-acting -agonists and ICSs is what happens to patients on this therapy during an asthma exacerbation. The existing data indicate that when combination therapy was compared with high-dose ICSs alone, it did not alter the ability to detect deteriorating asthma, it led to faster recovery after an exacerbation, it did not disguise deteriorating asthma, and it did not increase/mask airway inflammation. This study also examines how to approach patients placed on this dual controller therapy after control of their asthma is attained. Suggestions for the transition from initial therapy to maintenance therapy that may involve single controller medications are made. Innovative methods of handling asthma exacerbations with dual controller therapy also are made.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Regular Paper

Publication date: 01 March 2003

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more